Literature DB >> 32888934

May the epimastigote form of Trypanosoma cruzi be infective?

Wanderley De Souza1, Emile S Barrias2.   

Abstract

For many years it has been considered that there are three basic developmental stages of Trypanosoma cruzi: Epimastigote (Epi), Amastigote (Ama) and Trypomastigote (Typo). Epi and Ama are able to divide while Trypo does not divide. Epi are not infective while Ama and Trypo are able to infect host cells. Here we review the available data for the epimastigote form. Taken together the data show that (a) there are intermediate forms between epimastigotes and trypomastigotes in axenic cultures as well as between amastigote and trypomastigote forms within the cells (both in vitro and in vivo), and (c) that the intermediate forms, here designated as "Transitional Epimastigote", most of the time considered as epimastigotes, are able to infect cells. The recognition of the existence of this stage is of practical importance for those work with T. cruzi. Many laboratories working only with T. cruzi in axenic cultures usually consider to work with nonpathogenic cultures. This attitude needs to be changed requiring special care by those working with this protozoan to avoid accidental infections in the laboratory. In view of these observation a new scheme for the life cycle of T. cruzi is proposed.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Infection; Infective epimastigotes; Infective forms; T. cruzi

Mesh:

Year:  2020        PMID: 32888934     DOI: 10.1016/j.actatropica.2020.105688

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  4 in total

1.  Aflagellar Epimastigote of Trypanosoma caninum: Biological and Ultrastructural Study of this Atypical Evolutionary Form.

Authors:  Kátia Cristina Silva Nascimento; Sandra Maria de Oliveira Souza; Aline Fagundes; Roger Magno Macedo Silva; Francisco Odencio Rodrigues de Oliveira Junior; Suzana Corte-Real; Juliana Helena da Silva Barros
Journal:  Acta Parasitol       Date:  2022-04-05       Impact factor: 1.440

Review 2.  Extracellular Vesicles: Potential Role in Remote Signaling and Inflammation in Trypanosoma cruzi-Triggered Disease.

Authors:  Luíza Dantas-Pereira; Rubem Menna-Barreto; Joseli Lannes-Vieira
Journal:  Front Cell Dev Biol       Date:  2021-12-20

3.  New Amino Naphthoquinone Derivatives as Anti-Trypanosoma cruzi Agents Targeting Trypanothione Reductase.

Authors:  Christian Espinosa-Bustos; Mariana Ortiz Pérez; Alonzo Gonzalez-Gonzalez; Ana María Zarate; Gildardo Rivera; Javier A Belmont-Díaz; Emma Saavedra; Mauricio A Cuellar; Karina Vázquez; Cristian O Salas
Journal:  Pharmaceutics       Date:  2022-05-25       Impact factor: 6.525

4.  Silver Nanoparticles Containing Fucoidan Synthesized by Green Method Have Anti-Trypanosoma cruzi Activity.

Authors:  Adriana Oliveira Souza; Johny Wysllas de Freitas Oliveira; Claudia Jéssica Gonsalves Moreno; Mayra Jane Campos de Medeiros; Marília Medeiros Fernandes-Negreiros; Flavia Roberta Monteiro Souza; Daniel Lima Pontes; Marcelo Sousa Silva; Hugo Alexandre Oliveira Rocha
Journal:  Nanomaterials (Basel)       Date:  2022-06-15       Impact factor: 5.719

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.